Nocturol, Inc

Headquarters

Unknown, US

Nocturol, Inc. is a pharmaceutical company developing Nocturol™ (Paxerol®), a low-dose combination of acetaminophen and ibuprofen in an extended-release formulation, to treat nocturia by inhibiting prostaglandin overproduction. The company is currently in Phase 2 clinical trials and holds multiple patents for its method of use.

• Egalet CorporationEgalet Corporation is a fully integrated specialty pharmaceutical company focused on developing, manufacturing, and commercializing innovative treatments for pain. The company uses proprietary Guardian Technology to create abuse-deterrent oral products and markets approved products including OXAYDO™, SPRIX®, and ARYMO™ ER.WAYNE, PA
• iCeuticaiCeutica is a pharmaceutical research and development company that applies its proprietary SoluMatrix Fine Particle Technology to create new branded medicines with improved efficacy, better side effect profiles, and more convenient dosing. The company works with pharmaceutical partners and advances its own pipeline of product candidates for pain and inflammation, oncology, and respiratory diseases.KING OF PRUSSIA, PA
• MAXONA Pharmaceuticals, IncMAXONA Pharmaceuticals is a clinical-stage pharmaceutical company leveraging innovation to develop the next generation of therapies to help patients maximize life. MAXONA's initial focus is on addressing the urgent need for new effective therapies that treat acute and chronic pain, without the side effects and addiction risks associated with NSAIDS and opioids. MAXONA's lead compound, MAX-001 is a non-opioid, non-NSAID oral therapy with a novel mechanism of action that is initially being developed in the U.S. to treat acute and chronic pain.MALVERN, PA
• Harmony BiosciencesHarmony Biosciences is a U.S. commercial-stage pharmaceutical company dedicated to developing and commercializing innovative therapies for people living with rare neurological disorders who have unmet medical needs. The company focuses on sleep/wake, neurobehavioral, and rare epilepsy disorders.PLYMOUTH MEETING, PA